BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jaddoa E, Masania J, Masiero E, Sgamma T, Arroo R, Sillence D, Zetterström T. Effect of antidepressant drugs on the brain sphingolipid system. J Psychopharmacol 2020;34:716-25. [PMID: 32403969 DOI: 10.1177/0269881120915412] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 López-arnau R, Camarasa J, Carbó M, Nadal-gratacós N, Puigseslloses P, Espinosa-velasco M, Urquizu E, Escubedo E, Pubill D. 3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs. Front Psychiatry 2022;13:990405. [DOI: 10.3389/fpsyt.2022.990405] [Reference Citation Analysis]
2 Mucke HA. Drug Repurposing Patent Applications January–March 2022. ASSAY and Drug Development Technologies 2022;20:183-190. [DOI: 10.1089/adt.2022.033] [Reference Citation Analysis]
3 Kornhuber J, Gulbins E. New Molecular Targets for Antidepressant Drugs. Pharmaceuticals (Basel) 2021;14:894. [PMID: 34577594 DOI: 10.3390/ph14090894] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
4 Breiden B, Sandhoff K. Acid Sphingomyelinase, a Lysosomal and Secretory Phospholipase C, Is Key for Cellular Phospholipid Catabolism. Int J Mol Sci 2021;22:9001. [PMID: 34445706 DOI: 10.3390/ijms22169001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]